Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma
Anna Ludovica Fracanzani(University of Milan), Tomaso Stroffolini(Istituto Superiore di Sanità), Luca Valenti(University of Milan), Elisabetta Cariani(University of Parma), Silvia Fargion(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Maria Antonietta Stazi(Istituto Superiore di Sanità), Sonia Brescianini, Angelo Rossini(Centro Universitário Barão de Mauá), C. Bertelli(Ospedale Maggiore), Maurizio Tommasini(University of Milan), E. Fatta(Ospedale Maggiore), Pietro Amoroso(I.R.C.C.S. Oasi Maria SS), Angelo Sangiovanni(Ospedale Maggiore)
Cited by 35
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821